Tripeptide Compounds for Broad-Spectrum Pathogen Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sinusitis, pneumonia, and otitis media are hindered by the difficulty in identifying the causative agent, as symptoms can be similar regardless of whether the infection is bacterial, viral, or fungal, and existing antibacterial and antiviral agents are not effective against multiple types of pathogens.
Innovation Solution
Development of tripeptide compounds with cationic and bulky structures, such as LTX-109, which exhibit both antibacterial and antiviral activity, capable of targeting bacteria, viruses, and fungi, allowing for effective treatment regardless of the underlying causative agent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If antibacterial agents are used to treat sinusitis, pneumonia or otitis, then bacterial infections can be targeted, but viral and fungal infections remain untreated
Solution Approach 1:
The patent describes compounds with dual or triple activity (antibacterial plus antiviral, or antibacterial plus antifungal) that can treat multiple types of pathogens simultaneously. This allows a single compound to address bacterial, viral, and/or fungal infections, eliminating the need for separate medications for each pathogen type and enabling effective treatment regardless of the specific causative agent.
2Measurement precision
If laboratory tests are performed to identify the causative agent, then accurate diagnosis can be achieved, but treatment time is delayed
Solution Approach 1:
The patent enables clinicians to initiate treatment immediately with broad-spectrum compounds that cover multiple pathogen types without waiting for laboratory identification of the specific causative agent. The compounds are designed to be effective against bacteria, viruses, and/or fungi simultaneously, allowing treatment to begin at the point of diagnosis while laboratory testing proceeds in parallel.
3Adaptability or versatility
If multiple separate agents are used to cover different pathogen types, then comprehensive coverage is achieved, but treatment complexity increases
Solution Approach 1:
The patent combines multiple antimicrobial activities (antibacterial, antiviral, and/or antifungal) into single compounds. Instead of requiring separate medications for each pathogen type, the merged compounds provide comprehensive coverage through a single agent, simplifying the treatment regimen and improving patient compliance.
Data Source
AI summary
The present invention provides a compound for use in the treatment of sinusitis, pneumonia or otitis in a subject, wherein said compound is a compound of Formula (I) as defined herein: AA-AA-AA-X—Y—Z (I). The invention further provides a method of treating sinusitis, pneumonia or otitis in a subject, which method comprises administering to a subject in need thereof an effective amount of a compound of Formula (I).